With these declarations, the areas can use funds to help with preparedness and response to prevent the further spread of the disease.
Monkeypox (Adobe Stock)
This article was originally published on contagionlive.com.
Monkeypox incidence rates continue to grow prompting both New York State and the city of San Francisco to declare local public health emergencies for the virus in recent days. This comes after July 23, 2022, when the World Health Organization declared monkeypox a global health emergency.
According to the latest Centers for Disease Control and Prevention (CDC) statistics provided on July 29, there were 5189 confirmed monkeypox/orthopoxvirus cases in the US.
New York State alone accounted for 1345 cases, and the state of California had 799.
"Based on the ongoing spread of this virus, which has increased rapidly and affected primarily communities that identify as men who have sex with men, and the need for local jurisdictions to administer vaccines, I've declared monkeypox an Imminent Threat to Public Health throughout New York State," NY State Commissioner of Health Mary T. Bassett, MD, MPH, said in a statement. "This declaration means that local health departments engaged in response and prevention activities will be able to access additional State reimbursement, after other Federal and State funding sources are maximized, to protect all New Yorkers and ultimately limit the spread of monkeypox in our communities."
New York has secured more than 60,000 doses of the JYNNEOS monkeypox vaccine to date, including those for New York City.
According to the New York State press release, officials said all New Yorkers can protect themselves and prevent the spread of monkeypox in their communities:
The San Francisco Department of Public Health (SFDPH) also declared a local emergency to strengthen the city’s preparedness and response to the rapidly rising cases of monkeypox. This announcement happened last Friday and they reported 261 confirmed cases of monkeypox in the city.
“We need to be prepared and this declaration will allow us to serve the city better,” said Director of Health Grant Colfax, MD, said in a statement. “Our COVID-19 response has taught us that it is imperative that we mobilize city resources. The declaration helps us ensure we have all the tools available to augment our outreach, testing and treatment, especially to the LGBTQ+ who remain at highest risk for monkeypox.”
San Francisco is expected to receive 4220 doses of the monkeypox vaccine. SFDPH initially requested 35,000 doses of the monkeypox vaccine to meet the needs of people in the city. Including this latest allocation, San Francisco has received approximately 12,000 doses.
From Sterilization Tech to Infection Control Advocate: Sherrie Busby’s Inspiring Dental Journey
February 20th 2025Sherrie Busby, EDDA, CDSO, CDIPC, shares her journey from dental assisting to infection control advocacy, highlighting her passion for education, her role at Heartland Dental, and her exciting transition to a new chapter.
Innovation and Infection Control: Highlights From W&H at Chicago Dental Midwinter Society Meeting
February 19th 2025Doris Schneider, senior marketing manager for North America for W&H North America, shares insights into the 160th Chicago Dental Society Midwinter Meeting, showcasing the Lexa Mini rapid sterilizer and Sanaa Power handpiece, designed for efficient sterilization and effortless dental procedures.
Why AL-CIP Certification Is a Game-Changer; Apply by February 28, 2025
February 17th 2025AL-CIP certification validates leadership in infection prevention, unlocking career growth and credibility. Hear from certified professionals on its impact and why you should apply today before applications close on February 28, 2025!
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.